Eliezer Van Allen, Chandra Nohria Family Chair for AI in Cancer Research at Dana-Farber Cancer Institute, Professor of Medicine at Harvard Medical School, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Here, we found out how liposarcomas – rare cancers arising from adipose precursor cells – can switch from indolent to lethal states.
A fascinating set of insights that even includes GLP-1 biology plus therapeutics in cancer! Congrats Erica Pimenta et al..”
Title: Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity
Authors: Erica Pimenta, Amanda Garza, Sabrina Camp, Jihye Park, Samantha Hoffman, Laura Valderrábano, Jingxin Fu, Kevin Bi, Julie Karam, Breanna Titchen, Melin Khandekar, Erin Shannon, Yun Jee Kang, Anwesha Nag, Aaron Thorner, Chandrajit Raut, Jason Hornick, Priscilla Merriam, Nicole Solimini, Suzanne George, George Demetri, Eliezer Van Allen
Read the Full Article in BioRxiv.
More posts featuring Eliezer Van Allen on OncoDaily.